Current Report Filing (8-k)
July 16 2021 - 2:58PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act
of 1934
Date of
Report (Date of earliest event reported)
July 13, 2021
AEHR TEST SYSTEMS
(Exact
name of registrant as specified in its charter)
|
California
|
|
000-22893
|
|
94-2424084
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
|
|
|
400 KATO TERRACE, FREMONT, CA 94539
|
|
(Address
of principal executive offices, including zip code)
|
|
|
|
510-623-9400
|
|
(Registrant’s
telephone number, including area code)
|
|
|
|
N/A
|
|
(Former
name or former address, if changed since last report)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate by check
mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
Trading
|
Name of
each exchange on which registered
|
|
|
Symbol(s)
|
|
|
Common
Stock, par value $0.01 per share
|
AEHR
|
The
NASDAQ Capital Market
|
Item 5.02. Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
On July 13, 2021, the board of directors of Aehr Test Systems (the
"Company"), upon recommendation from the compensation committee of
the Company, approved an increase to the annual stock option grant
to the Company's Chairman from 18,000 shares to 25,000 shares, and
other non-employee directors from 10,000 shares to 15,000
shares.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
Aehr Test Systems
(Registrant)
|
|
|
|
|
|
|
|
Date: July 16, 2021
|
By:
|
/s/ Kenneth B. Spink
|
|
|
|
|
Kenneth B. Spink
|
|
|
|
|
Vice President of Finance and
Chief Financial Officer
|
|
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Apr 2023 to Apr 2024
